covid
Buscar en
Anales de Pediatría Continuada
Toda la web
Inicio Anales de Pediatría Continuada Hiperamoniemias de origen metabólico: diagnóstico, seguimiento y tratamiento
Información de la revista
Vol. 2. Núm. 5.
Páginas 276-283 (enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 2. Núm. 5.
Páginas 276-283 (enero 2004)
Acceso a texto completo
Hiperamoniemias de origen metabólico: diagnóstico, seguimiento y tratamiento
Visitas
8614
Pablo Sanjurjo
Unidad de Metabolismo Pediátrico. Hospital de Cruces. Universidad del País Vasco. Vizcaya. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S. Grisolía, V. Rubio.
Algunos aspectos del ciclo de la urea.
Bioquímica y Biología molecular para posgraduados, pp. 173-180
[2.]
E. Zammarchi, F. Ciani, E. Pasquini, G. Bonocore, V.E. Shih, M.A. Donati.
Neonatal onset of hyperornithinemia-hyperammoniemia- homocitrullinuria syndrome with favorable outcome.
J Pediatr, 131 (1997), pp. 440-443
[3.]
M.L. Batshaw.
Inborn errors of urea synthesis.
Ann Neurol, 35 (1994), pp. 133-141
[4.]
J.V. Leonard.
Urea cycle disorders.
Inborn metabolic diseases, pp. 167-176
[5.]
M.L. Batshaw, M. Michael, A.L. Beaudet, J. Trojak.
Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.
J Pediatr, 108 (1986), pp. 236-241
[6.]
E.P. Di Magno, J.E. Lowe, P.J. Snodgrass, J.D. Jones.
Ornithine transcarbamylase deficiency. A cause of bizarre behavior in a man.
N Engl J Med, 315 (1986), pp. 744-747
[7.]
M. Msall, M.L. Batshaw, R. Suss, S.W. Brusilow, D.E. Mellits.
Neurologic outcome in children with inborn errors of urea synthesis.
N Engl J Med, 310 (1984), pp. 1500-1505
[8.]
P.C. Rowe, S.L. Newman, S.W. Brusilow.
Natural history of symptomatic partial ornithine transcarbamylase deficiency.
N Engl J Med, 314 (1986), pp. 541-547
[9.]
J. Connelly, D. Cross, J. Gadian, F. Hunter, J. Kirkham, J.V. Leonard.
Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency.
[10.]
E.R. Hauser, J.E. Finkelstein, D. Valle, S.W. Brusilow.
Allopurinol- induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.
N Engl J Med, 322 (1990), pp. 1641-1645
[11.]
G. Pintos, M.P. Briones, C. Marchante, P. Sanjurjo, M.A. Vilaseca.
Protocolo para el diagnóstico, tratamiento y seguimiento de los trastornos del ciclo de la urea.
An Esp Pediatr, (1997), pp. 1-8
[12.]
P. Sanjurjo, M. Montejo, M.A. García Cazorla, G. Pintos.
Errores innatos del ciclo de la urea.
Actualidad Nutricional, 24 (1998), pp. 16-21
[13.]
P. Sanjurjo Crespo, M. Saieta Altuna, V. Rubio Zamora, J.M. Prats Viñas, A. Vallo Boado.
El déficit en ornitin-transcarbamilasa: dificultades pronósticas.
An Esp Pediatr, 35 (1991), pp. 407-408
[14.]
N.E. Maestri, D. Clissold, S.W. Brusilow.
Neonatal onset transcarbamylase deficiency: A retrospective analysis.
J Pediatr, 134 (1999), pp. 268-272
[15.]
P. Sanjurjo, J. Rodriguez Soriano.
Management of neonatal citrullinemia.
J Pediatr, 123 (1993), pp. 838-839
[16.]
S.W. Brusilow, A.L. Horwich.
Urea cycle enzymes.
The metabolic and molecular bases of inherited disease, pp. 1187-1232
[17.]
R.M. Neil, N.G. Kennaway, C.A. Hepburn, J.J. Strandholm, M.S. Ramberg.
Citrullinemia: investigation and treatment over a four-year period.
J Pediatr, 85 (1997), pp. 208-214
[18.]
M.L. Batshaw, G.T. Berry.
Use of citrulline as a diagnostic marker in the prospective treatment of urea cycle disorders.
J Pediatr, 118 (1991), pp. 914-917
[19.]
Y. Ohtani, K. Ohyanagi, S. Yammamoto, I. Matsuda.
Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
J Pediatr, 112 (1988), pp. 409-414
[20.]
E. Mayatepek, T.W. Kurczynski, C.h.L. Hoppel, W.T. Gunning.
Carnitine deficiency associated with ornithine transcarbamylase deficiency.
Pediatr Neurol, 7 (1991), pp. 196-199
[21.]
C. Renner, A.C. Sewel, K. Bervoets, H. Föster, H. Bölhes.
Sodium citrate supplementation in inborn argininosuccinate lyase deficiency: a study in a 5-year-old patient under total parenteral nutrition.
Eur J Pediatr, 154 (1995), pp. 909-914
[22.]
B. Plecko, W. Erwa, B. Wermuth.
Partial N-acetylglutamate synthethase deficiency in a 13-years-old girl: diagnosis and response to treatment with N-carbamylglutamate.
Eur J Pediatr, 157 (1998), pp. 996-998
[23.]
N.E. Maestri, E. Hauser, D. Bartholomew, S.W. Brusilow.
Prospective treatment of urea cycle disorders.
J Pediatr, 119 (1991), pp. 923-928
[24.]
N.E. Maestri, K.D. McGowan, S. Brusilow.
Plasma glutamine concentration: a guide in the management of urea cycle disorders.
J Pediatr, 121 (1992), pp. 259-261
[25.]
S.W. Brusilow, Maestri.
Urea Cycle Disorders: Diagnosis, Pathophisiology, and Therapy.
Adv Pediatr, 43 (1996), pp. 127-170
[26.]
F. Feillet, J.V. Leonard.
Alternative pathway therapy for urea cycle disorders.
J Inher Met Dis, Supl 1 (1998), pp. 101-111
[27.]
M. Summar, J. Pietch, J. Deshpande, G. Schulman.
Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammoniemia.
J Pediatr, 128 (1996), pp. 379-382
[28.]
M. Kasahara, T. Kiuchi, K. Uryuhara, Y. Ogura, K. Takakura, H. Egawa, et al.
Treatment of ornithine transcarbamylasa deficiency in girls by auxiliary liver transplantation: conceptual changes in a living-donor program.
J Pediatr Surg, 33 (1998), pp. 1753-1756
[29.]
P.f. Whitington, E.M. Alonso, J.T. Boyle, J.P. Molleston, P. Rosenthal, J.C. Emond, et al.
Liver transplantation for the tratment of urea cycle disorders.
J Inherit Metab Dis, 1 (1998), pp. 112-118
[30.]
D. Rabier, C. Narcy, J. Bardet, P. Parvy, J.M. Saudubray, P. Kamoun.
Arginine remains an Essential Amino Acid after Liver Transplantation in Urea Cycle Enzyme Deficiencies.
J Inh Met Dis, 14 (1991), pp. 277-280
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos